- Home
- XBIT vs CFBK Comparison
XBIT vs CFBK Comparison
Compare XBIT & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- CFBK
- Stock Information
- Founded
- XBIT 2005
- CFBK 1892
- Country
- XBIT United States
- CFBK United States
- Employees
- XBIT N/A
- CFBK N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- CFBK Major Banks
- Sector
- XBIT Health Care
- CFBK Finance
- Exchange
- XBIT Nasdaq
- CFBK Nasdaq
- Market Cap
- XBIT 194.5M
- CFBK 177.5M
- IPO Year
- XBIT 2015
- CFBK 1998
- Fundamental
- Price
- XBIT $3.82
- CFBK $22.85
- Analyst Decision
- XBIT
- CFBK
- Analyst Count
- XBIT 0
- CFBK 0
- Target Price
- XBIT N/A
- CFBK N/A
- AVG Volume (30 Days)
- XBIT 94.6K
- CFBK 32.4K
- Earning Date
- XBIT 11-13-2024
- CFBK 02-05-2025
- Dividend Yield
- XBIT N/A
- CFBK 1.25%
- EPS Growth
- XBIT N/A
- CFBK N/A
- EPS
- XBIT N/A
- CFBK 2.04
- Revenue
- XBIT N/A
- CFBK $44,396,000.00
- Revenue This Year
- XBIT N/A
- CFBK N/A
- Revenue Next Year
- XBIT N/A
- CFBK N/A
- P/E Ratio
- XBIT N/A
- CFBK $10.92
- Revenue Growth
- XBIT N/A
- CFBK N/A
- 52 Week Low
- XBIT $3.51
- CFBK $16.92
- 52 Week High
- XBIT $9.96
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- XBIT 32.16
- CFBK 40.04
- Support Level
- XBIT $3.64
- CFBK $21.58
- Resistance Level
- XBIT $4.00
- CFBK $22.99
- Average True Range (ATR)
- XBIT 0.34
- CFBK 0.98
- MACD
- XBIT 0.02
- CFBK -0.12
- Stochastic Oscillator
- XBIT 17.48
- CFBK 33.62
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.